Hope for Alzheimer's? FDA approves Eli Lilly's groundbreaking treatment
Lilly’s drug Kisunla aims to slow the progression of the disease in its early stages. "This is real progress. Today's ...
Lilly’s drug Kisunla aims to slow the progression of the disease in its early stages. "This is real progress. Today's ...
Experts fear new mutation might be more infectious and resistant to vaccines. Pfizer asks the FDA to authorize extra-low doses ...
Over 1,000 Israelis test positive for the coronavirus for five consecutive days. FDA approves a second pill against COVID, providing ...
FDA approves Pfizer's coronavirus pill. Two British studies suggest Omicron variant might be milder than the Delta strain. In Israel, ...
While FDA had already authorized the shots, Center for Disease Control recommends who should receive the vaccine. The milestone opens ...
Military task force on coronavirus warns that "contrary to popular opinion, COVID-19 can pose serious danger to children." US intelligence: ...
Delta wave continues to subside in Israel as Health Ministry prepares for meeting on children's vaccine to be broadcast on ...
FDA endorses kid-size doses of Pfizer’s vaccine shots for 5-11-year-olds. Delta variant continues to subside across Israel, except for one ...
Survey finds 23% of parents to refuse to vaccinate children, while 29% remain undecided. Thirty-seven percent of those who said ...
PM Bennett orders experts to increase genetic testing of virus samples following discovery of Delta sub-variant in Israel. FDA approves ...
The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.
All rights reserved to Israel Hayom
Hosted by sPD.co.il
[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]